Category Archives: Polaris News

POLARISqb Receives DARPA IMPAQT Funding to Advance Quantum Computing for Drug Design
The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a research contract in support of their work designing drugs with quantum computers. The contract is a part of the Advanced Research Concept topic Imagining Practical Applications for a Quantum Tomorrow (IMPAQT). POLARISqb has been developing quantum computing methods for drug discovery since their inception in…
Read more
POLARISqb and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service
POLARISqb, the first company in the world to develop a drug discovery engine that utilizes the optimization power of quantum computing, announced that it has signed an MOU with Syntekabio (KOSDAQ: 226330), an Artificial Intelligence (AI) based drug development company. The partnership, which will combine the companies’ vanguard drug research platforms, will provide a collaborative…
Read more
White Paper on QuADD shows Marked Advantage Versus Conventional Library Builds
Polaris Quantum Biotech (POLARISqb) leverages quantum computing to accelerate drug discovery, revolutionizing the way that molecular drug design is accomplished. The company released a white paper on the advantages of using the POLARISqb platform Quantum-Aided Drug Design (QuADD) for library generation. An enriched starting library of diverse and drug-like molecules increases the probability of quickly…
Read more